The patent, filed under its anti-cancer research segment, covers new chemical compounds that target cancer stem cells. These compounds have shown strong potential in treating cancers such as breast and prostate.
The development strengthens the company’s research portfolio and marks a step forward in its efforts toward high-value therapeutic innovation.
Godavari Biorefineries is a leading integrated biorefinery specializing in bio-based chemicals, ethanol, and sugar & power production. The company one of the larger producers of ethanol and a pioneer in manufacturing ethanol-based chemicals in India. The company operates cutting-edge facilities in Sakarwadi, Maharashtra, and Sameerwadi, Karnataka and three advanced R&D facilities in Mumbai and plant locations.
On a consolidated basis, Godavari Biorefineries reported net loss of Rs 16.02 crore in Q1 June 2025 as against net loss of Rs 26.11 crore in Q1 June 2024. Net sales rose 2.05% YoY to Rs 533.24 crore in Q1 June 2025.